Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Baxalta now part of Shire
With
UDC Rare Bleeding and Clotting Disorders Working Group (RBDWG)
American Thrombosis and Hemostasis Network
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants for whom CEPROTIN therapy has been indicated and meeting the following criteria may be enrolled in this study:
Signed and dated informed consent from either the participant or the participant's legally authorized representative prior to enrollment, as applicable
Males and females of any age, including neonates, children, adolescents and adults
Participant who received CEPROTIN or is initiating/receiving CEPROTIN treatment
